Delivery Order 36F79718D0402-W81K0026FA028
- The Defense Health Agency awarded a $63,681.93 firm fixed-price purchase order to Lantheus Medical Imaging, Inc. for the supply of Technetium-99m generators and Xenon radiopharmaceuticals, with performance at JBSA Fort Sam Houston, Texas and a completion date of September 30, 2030. This contract was awarded without a set-aside designation on October 1, 2025. Lantheus Medical Imaging, a subsidiary of Lantheus Holdings, Inc., is a leading manufacturer of diagnostic medical imaging agents and...
- The Defense Health Agency awarded a $77,206.25 firm fixed-price purchase order to Lantheus Medical Imaging, Inc. for radiopharmaceuticals, with an ultimate completion date of September 30, 2026. The contract was awarded without a set-aside designation and involves performance at Fort Bliss, Texas. Lantheus Medical Imaging, a subsidiary of Lantheus Holdings, Inc., is a specialized manufacturer of diagnostic medical imaging agents and radiopharmaceutical products headquartered in North...
- Lantheus Medical Imaging, Inc. was awarded a $811,119.92 firm fixed-price definitive contract by the Defense Health Agency to supply TechneLite MO99/TC99m radiopharmaceutical generators and related nuclear medicine supplies to the Dwight D. Eisenhower Army Medical Center at Fort Gordon, Georgia. This total small business set-aside contract, effective February 3, 2020, with an ultimate completion date of February 2, 2025, fulfills the standing weekly order requirements identified in the...
- The Defense Health Agency awarded a $164,605.48 firm fixed price purchase order to Lantheus Medical Imaging, Inc. to supply TechneLite generators from October 2022 through September 2023. This contract has no set-aside designation. Lantheus Medical Imaging is a for-profit manufacturer that provides radiopharmaceutical products, including technetium-99m generators, xenon-133 gas, and other nuclear medicine supplies, to federal agencies such as the Department of Veterans Affairs and Department...
- The Defense Health Agency awarded a $163,181.72 firm fixed-price delivery order to Lantheus Medical Imaging, Inc. for the provision of thirty-nine TechneLite MO99/TC99M technetium-99m generators at Tripler Army Medical Center in Hawaii. The delivery order was issued on October 1, 2023, with an ultimate completion date of September 30, 2024. This award was executed without a small business set-aside designation and represents a task order against Lantheus Medical Imaging's $6.5 million blanket...
- Lantheus Medical Imaging, Inc. has been awarded a blanket purchase agreement call by the Defense Health Agency to provide radiopharmaceuticals and supplies. The single-award BPA, with a potential value of $100,000, enables the agency to acquire standardized radiotracers, technetium-99m generators, and other nuclear medicine products through September 2023 for use at military treatment facilities. Delivery will be to locations in El Paso, Texas. Pricing is set at firm fixed price. As the prime...
- The Defense Health Agency awarded a $168,497.89 firm fixed price delivery order to Lantheus Medical Imaging, Inc. under the Pharmaceuticals and Drugs GSA Schedule 61-IB contract. The contract is for the provision of radiopharmaceutical products for nuclear medicine, including technetium-99m generators, xenon-133 gas, sestamibi vials, and other nuclear medicine supplies. The contract is set aside for small businesses, and the products will be delivered to the Bethesda, Maryland area. Lantheus...
- The Defense Health Agency awarded a $66,256.48 firm fixed price blanket purchase agreement call contract to Lantheus Medical Imaging, Inc. for the delivery of radiopharmaceuticals. As the parent company, Lantheus Holdings, Inc. oversees performance of this contract. No set-aside provisions were specified in the award. Lantheus Medical Imaging will provide the radiopharmaceutical products to the Defense Health Agency from its place of performance in Fort Sam Houston, Texas, in support of the...
- This is a federal delivery order award made by the Defense Health Agency (DHA) to Lantheus Medical Imaging, Inc., a for-profit manufacturer of diagnostic medical imaging agents, nuclear medicine supplies, and radiopharmaceutical products. The award is for 4,500 TechneLite Mo/Tc99m generators, which are critical medical imaging equipment used in diagnostic procedures at military treatment facilities, VA medical centers, and other federal healthcare institutions. The contract is a firm fixed-price...
- This federal contract award to Lantheus Medical Imaging, Inc. is for the provision of TC-99M generators and radiopharmaceuticals to the Department of the Army Medical Command. The single-award, firm fixed price contract has a potential value of $170,911.62 and a completion date of September 30, 2020. This award is not associated with a set-aside designation. Lantheus Medical Imaging holds blanket purchase agreements with the Defense Health Agency to provide diagnostic nuclear imaging supplies...
- Pharmaceuticals and Drugs (FSS-61-IB)Master GSA Schedule
- 36F79718D0402Federal Supply Schedule
- 36F79718D0402-W81K0026FA028Delivery Order
Lantheus Medical Imaging, Inc., a subsidiary of Lantheus Holdings, Inc., was awarded a $244,610.96 firm fixed-price delivery order by the Defense Health Agency on January 1, 2026, for the supply of TechneLite MO99/TC99M generators and Xenon-133 gas to Brooke Army Medical Center at Joint Base San Antonio Fort Sam Houston, Texas. The contract has an ultimate completion date of December 31, 2026, and was awarded without a small business set-aside designation. Performance will be executed at Lantheus Medical Imaging's facility in North Billerica, Massachusetts. These radiopharmaceutical products are essential diagnostic imaging supplies used in nuclear medicine procedures to support the medical imaging capabilities of military treatment facilities. This delivery order is issued against Lantheus Medical Imaging's existing $6.5 million Blanket Purchase Agreement with the Defense Health Agency, established under the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB), which extends through July 27, 2028. As a critical supplier of nuclear medicine products and radiopharmaceuticals to federal healthcare agencies, Lantheus Medical Imaging has an established track record providing specialized diagnostic imaging agents to military treatment facilities and Department of Veterans Affairs medical centers nationwide. The firm fixed-price structure ensures cost certainty while enabling the Defense Health Agency to efficiently procure these specialized medical supplies on an as-needed basis to support diagnostic imaging operations across its network of military medical facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $244.6k | 12/18/25 |